Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04778592 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain
A Phase 2 study of Lumbosacral Radiculopathy, sponsored by Eliem Therapeutics (UK).
- Completed
- Registry status
- Phase 2
- Development phase
- 149
- Enrollment target
- 20
- Study locations
NCT04778592: Completed Phase 2 study of Lumbosacral Radiculopathy, sponsored by Eliem Therapeutics (UK).
NCT04778592 is a Phase 2 study of Lumbosacral Radiculopathy that has completed, run by Eliem Therapeutics (UK). The registered enrollment target is 149 participants, above the 30-participant average among 3 other Lumbosacral Radiculopathy trials with a reported enrollment target (397% higher). The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04778592, a Phase 2 study of Lumbosacral Radiculopathy, has completed, sponsored by Eliem Therapeutics (UK).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 149 participants
- Enrollment target
- 20
- Study locations
Study Summary
Efficacy and Safety of ETX 018810 in Subjects with Lumbosacral Radicular Pain
Primary Outcome
Change from baseline in the weekly average of the daily pain score as derived from the subject's responses on the Pain Intensity Numerical Rating Scale (PI-NRS), a 10 point scale from 0 being the least (No Pain) to 10 being the most (Worst Possible Pain).
Conditions Studied
Interventions
- DRUG Placebo
- DRUG ETX-018810
Study Locations (20)
Florida
- Charter Research - Lady Lake
- Cordova Research Institute - Miami
- Advanced Medical Research Institute - Miami
- Coral Research Clinic Corp - Miami
Georgia
- Drug Studies America - Marietta
- Better Health Clinical Research - Newnan
New York
- Drug Trials America - Hartsdale
- University of Rochester Translational Pain Research - Rochester
Alabama
- Delta Clinical Research - Mobile
Arizona
- Arizona Research Center - Phoenix
Colorado
- DBPS Research LLC - Greenwood Village
Idaho
- Injury Care Research - Boise
Illinois
- Chicago Anesthesia Research Specialist - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2021-01-19 |
| Est. Completion | 2022-05-25 |
| Phase | Phase 2 |
What the finished NCT04778592 record still lists
NCT04778592 is an interventional study that assigns participants to a tested intervention. The registered 149 participants enrollment target is mid-sized for trials with a published cap, above the 30-participant average among 3 other Lumbosacral Radiculopathy trials with a reported enrollment target (397% higher).
The record links to 1 condition, with Lumbosacral Radiculopathy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04778592 names 20 study sites across 15 states, led by Florida, Georgia, New York.
Frequently Asked Questions
What is clinical trial NCT04778592 about?
NCT04778592 is a clinical study titled "Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain". Efficacy and Safety of ETX 018810 in Subjects with Lumbosacral Radicular Pain
What is the current status of trial NCT04778592?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 149 participants. The study started on 2021-01-19. Estimated completion is 2022-05-25.
What conditions does trial NCT04778592 study?
This clinical trial studies the following conditions: Lumbosacral Radiculopathy.
What interventions are being tested in trial NCT04778592?
The interventions under investigation include: Placebo (DRUG), ETX-018810 (DRUG).
Who is sponsoring clinical trial NCT04778592?
This trial is sponsored by Eliem Therapeutics (UK), which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04778592 being conducted?
This trial has 20 study locations across Alabama, Arizona, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lumbosacral Radiculopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy
COMPLETED · Phase 2
-
A Multicomponent Intervention for Patients With Lumbosacral Radiculopathy: Move-MORE
RECRUITING · NA
-
A Long-term, 3-Year, Follow-up Study for Patients Completing the KS-GIG-001-01 Study
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04188535 · 149 participants · NA
Serial MRI Scans During Radiation Therapy
- NCT05828511 · 149 participants · Phase 1
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI